We reported that phorbol myristate acetate (PMA) stimulated polymorphonuclear leukocytes (PMN) from healthy humans, but not from persons with chronic granulomatous disease (CGD) increased transfer of albumin across an intact microvasculature (isolated perfused lung) and across monolayers of cultured endothelial cells. Direct observation of endothelial monolayers exposed to PMA-stimulated PMN demonstrated retraction of adjacent endothelial cells from each other. These reports suggested that reactive oxygen molecules, released from inflammatory cells, could alter endothelial cell shape and the transfer of albumin across an endothelium. More recently we observed that a brief exposure of endothelium to oxidants generated by xanthine and xanthine oxidase caused a 100% increase in albumin transfer across endothelium and that transfer returned to normal within 3.5 hours if the endothelium was reincubated in tissue culture medium enriched with 10% fetal bovine serum. The serum was necessary since reincubation in tissue culture medium alone resulted in progressive injury. Serum could not be replaced by a general antioxidant or by antiproteases. The effects of xanthine oxidase on albumin transfer were blocked by lanthanum chloride, and endothelial cell lysis by xanthine oxidase was inhibited by chelation of extracellular calcium. The changes in albumin transfer were associated with reversible retraction of adjacent cells from one another and the retraction was also prevented by LaCl3. This data suggests that oxidants can reversibly alter endothelial cell shape and that Ca++ is important to this process. The proposed studies extend these observations. One group of experiments will determine if the effects of oxidants are reversible in individual endothelial cells. Another group will investigate how oxidants alter endothelial calcium homeostasis. A third group will investigate oxidant stimulation of phospholipase activity and the last group will investigate how serum enables endothelium to reverse the oxidant injury. These investigations should increase our understanding of how oxidants affect endothelium and are relevant to acute inflammation and to atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033540-02
Application #
3345509
Study Section
Pathology A Study Section (PTHA)
Project Start
1985-07-01
Project End
1989-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Shasby, D Michael; Winter, Michael C (2011) H1 and PAR2 receptors enhance delivery of immune-competent cells and molecules by interrupting E-cadherin adhesion in epithelia. Trans Am Clin Climatol Assoc 122:217-28
Winter, Michael C; Shasby, Sandra; Shasby, D Michael (2008) Compromised E-cadherin adhesion and epithelial barrier function with activation of G protein-coupled receptors is rescued by Y-to-F mutations in beta-catenin. Am J Physiol Lung Cell Mol Physiol 294:L442-8
Winter, Michael C; Shasby, Sandra S; Ries, Dana R et al. (2006) PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: protective effect of beta-agonists. Am J Physiol Lung Cell Mol Physiol 291:L628-35
Winter, Michael C; Shasby, Sandra S; Ries, Dana R et al. (2004) Histamine selectively interrupts VE-cadherin adhesion independently of capacitive calcium entry. Am J Physiol Lung Cell Mol Physiol 287:L816-23
Zabner, Joseph; Winter, Michael; Excoffon, Katherine J D Ashbourne et al. (2003) Histamine alters E-cadherin cell adhesion to increase human airway epithelial permeability. J Appl Physiol 95:394-401
Moy, A B; Winter, M; Kamath, A et al. (2000) Histamine alters endothelial barrier function at cell-cell and cell-matrix sites. Am J Physiol Lung Cell Mol Physiol 278:L888-98
Winter, M C; Kamath, A M; Ries, D R et al. (1999) Histamine alters cadherin-mediated sites of endothelial adhesion. Am J Physiol 277:L988-95
Moy, A B; Bodmer, J E; Blackwell, K et al. (1998) cAMP protects endothelial barrier function independent of inhibiting MLC20-dependent tension development. Am J Physiol 274:L1024-9
Shasby, D M; Stevens, T; Ries, D et al. (1997) Thrombin inhibits myosin light chain dephosphorylation in endothelial cells. Am J Physiol 272:L311-9
Bodmer, J E; Van Engelenhoven, J; Reyes, G et al. (1997) Isometric tension of cultured endothelial cells: new technical aspects. Microvasc Res 53:261-71

Showing the most recent 10 out of 33 publications